EUVIMEDEUVIMED entdecken
Crossref

Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use

Anna Tomaszuk-Kazberuk, Lopatowska Paulina, Mlodawska Elzbieta, Sobkowicz Bozena

European Journal of Translational and Clinical Medicine · 2019

DOI: 10.31373/ejtcm/109298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Translational and Clinical Medicine, 2019. Verfasst von Anna Tomaszuk-Kazberuk und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tomaszuk-Kazberuk, A., Paulina, L., Elzbieta, M., & Bozena, S. (2019). Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use. European Journal of Translational and Clinical Medicine. https://doi.org/10.31373/ejtcm/109298

Vancouver

Tomaszuk-Kazberuk A, Paulina L, Elzbieta M, Bozena S. Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use. European Journal of Translational and Clinical Medicine. 2019. doi:10.31373/ejtcm/109298

BibTeX
@article{TomaszukKazberuk2019,
  author = {Tomaszuk-Kazberuk, Anna and Paulina, Lopatowska and Elzbieta, Mlodawska and Bozena, Sobkowicz},
  title = {Postponed absorption of dabigatran in a patient with paralytic ileus – difficulties in decision making on reversal agent (idarucizumab) use},
  journal = {European Journal of Translational and Clinical Medicine},
  year = {2019},
  doi = {10.31373/ejtcm/109298}
}
Kostenlos starten →